Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Thirty‐three healthy male and female volunteers aged 21 to 87 years received a single 0.5 mg oral dose of triazolam. Plasma triazolam concentrations were measured in multiple samples drawn during 24 h after the dose. Mean triazolam elimination half‐life was not significantly different between young and elderly men (3.0 vs 4.6 h), nor between young and elderly women (2.7 vs 3.2 h). However, apparent oral clearance of triazolam was significantly reduced in elderly as compared to young groups of both sexes, leading to higher peak plasma concentrations and increased total area under the curve. Values of half‐ life and clearance of antipyrine, a low‐extraction hepatically oxidized compound, were poorly correlated with those of triazolam (r = 0.34 and 0.44, respectively), suggesting different mechanisms controlling age‐ related changes in clearance of these two hepatically oxidized drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680119 · Cited by 197
Self-citationGreenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710227 · Cited by 134
Self-citation
Cited by
The effect of age upon liver volume and apparent liver blood flow in healthy man
Wynne, H. A., Cope, L. H., Mutch, E., Rawlins, M. D., Woodhouse, K. W., & James, O. F. W. (1989) · Hepatology · doi:10.1002/hep.1840090222 · Cited by 652
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Self-citationThe Aging Liver: Drug Clearance and an Oxygen Diffusion Barrier Hypothesis
Le Couteur, D. G., & McLean, A. J. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834050-00003 · Cited by 308
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
Self-citationSensitivity to triazolam in the elderly
Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258
Self-citation
Metadata
- Authors
- Greenblatt, D., Divoll, M., Abernethy, D., Moschitto, L., Smith, R., & Shader, R.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1983-03
- Volume
- 15
- Issue
- 3
- Pages
- 303-309
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2024185962
- Cited by
- 92
- References
- 3
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. https://app.cochat.ai/papers/10.1111/j.1365-2125.1983.tb01503.x
- The paper
- Greenblatt, D., Divoll, M., Abernethy, D., Moschitto, L., Smith, R., & Shader, R. (1983). Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1983.tb01503.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.